Lytix reports phase II results showing durable responses in advanced melanoma

Rznomics reports RZ-001 interim clinical data in hepatocellular carcinoma at AACR 2026

Akeso presents positive Phase II results from cadonilimab combination study at AACR 2026

GSK secures China approval for Blenrep in relapsed multiple myeloma

Accent Therapeutics presents ATX-295 data at AACR Annual Meeting 2026

10x Genomics introduces new in situ spatial biology platform

Whitehawk Therapeutics presents ADC preclinical data at AACR 2026

Kura Oncology reports early activity for darlifarnib–cabozantinib combination in cabozantinib‑pretreated ccRCC

Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic

Bold Therapeutics reports protection against chemotherapy-induced peripheral neuropathy with BOLD-100 anticancer agent

Philips secures FDA clearance for Spectral CT Verida system

Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology

Poolbeg Pharma secures MHRA approval for POLB 001 trial as US research highlights multi-billion dollar potential

Asgard Therapeutics appoints chief medical officer

Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting